Skip to content

Investigation of the effect of cerebrolysin in patients with Moderate level of consciousness induced by head trauma

Investigation of the effect of cerebrolysin in patients with moderate Glasgow coma scale induced by head trauma

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015052920948N2
Enrollment
48
Registered
2015-07-07
Start date
2015-05-14
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Trauma. Commotio cerebri

Interventions

Intervention 1: Intervention group: injection 10 mg serebrolysin. Intervention 2: Control Group: injection 10 mg distilled water.
Treatment - Drugs
Placebo
Intervention group: injection 10 mg serebrolysin
Control Group: injection 10 mg distilled water

Sponsors

Vice Chancellor for Research, Ahvaz Jundishapur University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion Criteria:Brain Traumatic patient with >18 years old and admission on <48 hours . Exclusion Criteria: Severe kidney disease, liver disease , lung disease or heart disease, history of stroke , pregnant patients, patients with evidence of Grand mal seizure or status epileptics

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Level of consciousness. Timepoint: 24h,48h and one week after admission. Method of measurement: Glasgow coma scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Mohammad Ali Mortazaviha

Ahvaz Jondishapour University of Medical Sciences

mortazaviha.sma@ajums.ac.ir+98 61 3333 8989

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026